Precigen, Inc. (PGEN)
4.18
-0.08
(-1.88%)
USD |
NASDAQ |
Dec 31, 16:00
4.175
0.00 (0.00%)
After-Hours: 20:00
Precigen Total Liabilities (Quarterly): 129.40M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.346M |
| ADMA Biologics, Inc. | 137.50M |
| Omeros Corp. | 406.18M |
| GeoVax Labs, Inc. | 1.824M |
| Vistagen Therapeutics, Inc. | 14.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 171.26M |
| Shareholders Equity (Quarterly) | 41.87M |
| Debt to Equity Ratio | 2.345 |
| Current Ratio | 4.041 |
| Net Debt Paydown Yield | -1.58% |